Search results for "Epidemiology"

showing 10 items of 4214 documents

Eating at restaurants, at work or at home. Is there a difference? A study among adults of 11 European countries in the context of the HECTOR* project

2016

BACKGROUND/OBJECTIVES: To compare macronutrient intakes out of home-by location-to those at home and to investigate differences in total daily intakes between individuals consuming more than half of their daily energy out of home and those eating only at home.SUBJECTS/METHODS: Data collected through 24-h recalls or diaries among 23766 European adults. Participants were grouped as 'non-substantial', 'intermediate' and 'very substantial out-of-home' eaters based on energy intake out of home. Mean macronutrient intakes were estimated at home and out of home (overall, at restaurants, at work). Study/cohort-specific mean differences in total intakes between the 'very substantial out-of-home' and…

AdultMale0301 basic medicineGerontologyRestaurantsAlcohol DrinkingMedicine (miscellaneous)Context (language use)610 Medicine & healthDiet SurveysEating03 medical and health sciencesSex FactorsFeeding behaviorSex factorsEnvironmental healthDietary CarbohydratesHumansMedicine030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryAdult; Alcohol Drinking; Diet; Diet Records; Diet Surveys; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; Europe; Female; Humans; Linear Models; Male; Mental Recall; Sex Factors; Eating; Feeding Behavior; RestaurantsDietary intakeHealth sciences Medical and Health sciencesCiências médicas e da saúde2701 Medicine (miscellaneous)Feeding Behavior10060 Epidemiology Biostatistics and Prevention Institute (EBPI)medicine.diseaseDietary FatsObesityDiet RecordsDiet SurveysDietEuropeWork (electrical)Mental RecallLinear ModelsMedical and Health sciences2916 Nutrition and DieteticsFemaleDietary ProteinsCiências da Saúde Ciências médicas e da saúdeEnergy IntakebusinessBody mass index
researchProduct

A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in pati…

1993

After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cytotoxic chemotherapy were randomized to receive placebo or subcutaneous granulocyte - colony stimulating factor (G- CSF) 5 μg/Kg/day in order to prevent severe neutropenia and its related morbidity. The incidence of neutropenia (absolute neutrophil count <1, 000/mm3) was significantly reduced in patients receiving G-CSF than in controls (18% versus 42%; P <0.05). The duration of neutropenia was also shortened by the administration of G-CSF (4.8 versus 8.2 days; P <0.05). Therapy with G-CSF has also a positive impact on the dose-intensity of employed regimens. Patients treated with G-CSF showed…

AdultMale0301 basic medicineMicrobiology (medical)medicine.medical_specialtyNeutropeniaTime FactorsFeverInjections Subcutaneousmedicine.medical_treatment030106 microbiologyAntineoplastic AgentsNeutropeniaGranulocytePlaceboGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansPharmacology (medical)Prospective StudiesNeoplasm MetastasisAgedPharmacologyChemotherapybusiness.industryIncidenceIncidence (epidemiology)CarcinomaMiddle Agedmedicine.diseaseRecombinant ProteinsGranulocyte colony-stimulating factorSurgeryInfectious DiseasesGranulocyte macrophage colony-stimulating factormedicine.anatomical_structureOncology030220 oncology & carcinogenesisAbsolute neutrophil countFemalebusinessmedicine.drug
researchProduct

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries

2016

AbstractWe aimed at investigating the distribution and risk of second primary cancers (SPCs) in multiple myeloma (MM) survivors in Germany and Sweden to provide etiological understanding of SPCs and insight into their incidence rates and recording practices. MM patients diagnosed in 1997–2010 at age ≥15 years were selected from the Swedish (nationwide) and 12 German cancer registries. Standardized incidence ratios (SIRs) were used to assess risk of a specific SPC compared to risk of the same first cancer in the corresponding background population. Among 18,735 survivors of first MM in Germany and 7,560 in Sweden, overall 752 and 349 SPCs were recorded, respectively. Significantly elevated S…

AdultMale0301 basic medicineOncologyPediatricsmedicine.medical_specialtyTime FactorsMyeloidAdolescentNervous System NeoplasmsPopulationAntineoplastic AgentsArticle03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicinemedicineHumansRegistriesSurvivorseducationMultiple myelomaAgedSwedeneducation.field_of_studyMultidisciplinarybusiness.industryIncidence (epidemiology)CancerNeoplasms Second PrimaryMiddle Agedmedicine.diseaseKidney NeoplasmsLeukemia Myeloid AcuteLeukemiaEarly Diagnosis030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisEpidemiology ; Cancer epidemiology ; MyelomaEtiologyFemaleMultiple MyelomabusinessKidney cancerScientific Reports
researchProduct

Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment

2016

Strong evidence for the statistical association between radiation exposure and disease has been produced for thyroid cancer by epidemiological studies after the Chernobyl accident. However, limitations of the epidemiological approach in order to explore health risks especially at low doses of radiation appear obvious. Statistical fluctuations due to small case numbers dominate the uncertainty of risk estimates. Molecular radiation markers have been searched extensively to separate radiation-induced cancer cases from sporadic cases. The overexpression of the CLIP2 gene is the most promising of these markers. It was found in the majority of papillary thyroid cancers (PTCs) from young patients…

AdultMale0301 basic medicineOncologyRisk analysisCancer Researchmedicine.medical_specialtyMedical surveillanceNeoplasms Radiation-InducedAdolescentThyroid GlandOriginal ManuscriptDisease03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologyBiomarkers TumormedicineHumansThyroid NeoplasmsChildThyroid cancerbusiness.industryCarcinomaCancerGeneral Medicinemedicine.diseaseCarcinoma Papillary3. Good healthBiomarker (cell)Gene Expression Regulation Neoplastic030104 developmental biologyChernobyl Nuclear AccidentThyroid Cancer Papillary030220 oncology & carcinogenesisFemaleRisk assessmentbusinessMicrotubule-Associated ProteinsCarcinogenesis
researchProduct

Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation

2018

Abstract Objectives Most studies identifying inflammatory markers for early detection of colorectal cancer (CRC) were conducted using clinically manifest cases. We aimed to identify circulating inflammatory biomarkers for early detection of CRC and validate them in both a clinical setting and a true screening setting. Study Design and Setting A total of 92 inflammatory proteins were quantified in baseline plasma samples from individuals clinically diagnosed with CRC and neoplasm-free controls matched on age and sex (training set). A multimarker panel was selected and evaluated in samples from another clinical setting (validation set C) and a screening setting (validation set S). Results In …

AdultMale0301 basic medicineOncologymedicine.medical_specialtyEpidemiologyColorectal cancerEarly detectionSensitivity and Specificity03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumorHumansMedicineProspective StudiesBiomarker discoveryEarly Detection of CancerAgedAged 80 and overTraining setColorectal cancer early detectionbusiness.industryMiddle AgedCancer Early Detectionmedicine.diseaseInflammatory biomarkers030104 developmental biologyArea Under Curve030220 oncology & carcinogenesisBiomarker (medicine)FemaleColorectal NeoplasmsbusinessAlgorithmsJournal of Clinical Epidemiology
researchProduct

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

2018

IF 15.132 (2017); International audience; Inherited loci have been found to be associated with risk of chronic lymphocytic leukemia (CLL). A combined polygenic risk score (PRS) of representative single nucleotide polymorphisms (SNPs) from these loci may improve risk prediction over individual SNPs. Herein, we evaluated the association of a PRS with CLL risk and its precursor, monoclonal B-cell lymphocytosis (MBL). We assessed its validity and discriminative ability in an independent sample and evaluated effect modification and confounding by family history (FH) of hematological cancers. For discovery, we pooled genotype data on 41 representative SNPs from 1499 CLL and 2459 controls from the…

AdultMale0301 basic medicineOncologymedicine.medical_specialtyLymphocytosisClinical Trials and ObservationsChronic lymphocytic leukemiaImmunologySingle-nucleotide polymorphism[SDV.CAN]Life Sciences [q-bio]/CancerLymphocytosisPolymorphism Single NucleotideBiochemistry03 medical and health sciences0302 clinical medicineRisk Factorsimmune system diseasesInternal medicinehemic and lymphatic diseasesGenotypeOdds RatiomedicineHumansGenetic Predisposition to Disease10. No inequalityAgedAged 80 and overB-Lymphocytesbusiness.industryConfoundingCell BiologyHematologyOdds ratioMiddle Agedmedicine.diseaseLeukemia Lymphocytic Chronic B-Cell3. Good health030104 developmental biologyGenetic epidemiologyGenetic Loci030220 oncology & carcinogenesisMonoclonal B-cell lymphocytosisFemalemedicine.symptombusiness
researchProduct

HPV infection in semen: results from a new molecular approach

2019

AbstractHuman papillomavirus (HPV) is the agent of the most common sexually transmitted diseases causing a variety of clinical manifestations ranging from warts to cancer. Oncogenic HPV infection is the major cause of cervical cancer and less frequently of penile cancers. Its presence in semen is widely known, but the effects on fertility are still controversial. We developed a new approach to evaluate virus localisation in the different semen components. We analysed also the specific genotype localisation and viral DNA quantity by qPCR. Results show that HPV DNA can be identified in every fraction of semen: spermatozoa, somatic cells and seminal plasma. Different samples can contain the HP…

AdultMale0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypesexually transmitted diseasesEpidemiologySemenSettore BIO/11 - Biologia MolecolareBiologyVirusmale infertilityMale infertilityYoung Adult03 medical and health sciences0302 clinical medicineSemenGenotypePrevalencemedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaPapillomaviridaesemen parametersCervical cancerOriginal Paper030219 obstetrics & reproductive medicinePapillomavirus InfectionsHPV infectionvirus diseasesCancersexually transmitted diseaseMiddle Agedsemen infectionmedicine.diseaseVirologySpermSettore MED/40 - Ginecologia E Ostetricia030104 developmental biologyInfectious DiseasesItalyDNA ViralHPV infectionsemen parameterviral infection
researchProduct

Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma

2017

Incidence rates for urothelial carcinoma (UC) have been reported to differ between countries within the European Union (EU). Besides occupational exposure to chemicals, other substances such as tobacco and nitrite in groundwater have been identified as risk factors for UC. We investigated if regional differences in UC incidence rates are associated with agricultural, industrial and residential land use.Newly diagnosed cases of UC between 2003 and 2010 were included. Information within 364 administrative districts of Germany from 2004 for land use factors were obtained and calculated as a proportion of the total area of the respective administrative district and as a smoothed proportion. Fur…

AdultMale0301 basic medicineUrologic NeoplasmsCancer ResearchMultivariate analysisAdolescentEpidemiologyYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyHumansIndustryMedicinemedia_common.cataloged_instanceYoung adultEuropean unionChildSocioeconomic statusAgedmedia_commonAged 80 and overLand usebusiness.industryIncidenceIncidence (epidemiology)SmokingAgricultureEnvironmental ExposureEnvironmental exposureMiddle Aged030104 developmental biologySocioeconomic FactorsOncologyAdministrative District030220 oncology & carcinogenesisFemalebusinessDemographyCancer Epidemiology
researchProduct

Does higher education protect against obesity? Evidence using Mendelian randomization

2017

Objectives. The aim of this explorative study was to examine the effect of education on obesity using Mendelian randomization. Methods. Participants (N = 2011) were from the on- going nationally representative Young Finns Study (YFS) that began in 1980 when six cohorts (aged 30, 33, 36, 39, 42 and 45 in 2007) were recruited. The average value of BMI (kg/m(2)) measurements in 2007 and 2011 and genetic information were linked to comprehensive register based information on the years of education in 2007. We first used a linear regression (Ordinary Least Squares, OLS) to estimate the relationship between education and BMI. To identify a causal relationship, we exploited Mendelian randomization …

AdultMale0301 basic medicinemedicine.medical_specialtyobesityschoolingEpidemiology515 PsychologyProtective factorBody Mass Index03 medical and health sciencesbody weightBMI0302 clinical medicineWaist–hip ratioInternal medicineLinear regressionMendelian randomizationmedicineHumans030212 general & internal medicineFinlandGenetic associationeducationbusiness.industryPublic Health Environmental and Occupational Healthta3141ylipainota3142Mendelian Randomization Analysista3121medicine.diseaseObesityConfidence interval030104 developmental biologyEndocrinologykoulutusOrdinary least squaresEducational StatuslihavuusFemalewaist-hip ratiobusinessGenome-Wide Association StudyDemographyPreventive Medicine
researchProduct

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis

2021

AdultMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)prospective cohortMEDLINEDermatologyregistryimmunosuppressive agentsSeverity of Illness IndexCOVID-19 (Malaltia)ArticleCohort StudiesInternal medicinePandemicPsoriasisHumansMedicinebiologic therapyRegistriesAgedbusiness.industryIncidenceIncidence (epidemiology)COVID-19COVID-19 Psoriasis biologic therapy immunosuppressive agents pharmacovigilance prospective cohort registryMiddle AgedSpainpharmacovigilanceFemalebusinessPsoriasi -- TractamentCohort studyJournal of the American Academy of Dermatology
researchProduct